ULTRAGENYX PHARMACEUTICAL IN's ticker is RARE and the CUSIP is 90400D108. A total of 232 filers reported holding ULTRAGENYX PHARMACEUTICAL IN in Q3 2022. The put-call ratio across all filers is 0.85 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $19,393,600 | -53.3% | 544,000 | -39.6% | 0.78% | -46.2% |
| Q2 2023 | $41,549,291 | -51.3% | 900,700 | -57.7% | 1.45% | -48.7% |
| Q1 2023 | $85,288,690 | -38.4% | 2,126,900 | -28.9% | 2.83% | -5.7% |
| Q4 2022 | $138,526,700 | +63.1% | 2,990,000 | +45.7% | 3.00% | +73.8% |
| Q3 2022 | $84,957,000 | -3.7% | 2,051,600 | +38.7% | 1.73% | -14.8% |
| Q2 2022 | $88,267,000 | +39.9% | 1,479,500 | +70.3% | 2.03% | +54.2% |
| Q1 2022 | $63,107,000 | +7.2% | 869,000 | +24.1% | 1.31% | +5.3% |
| Q4 2021 | $58,863,000 | +43.4% | 700,000 | +53.8% | 1.25% | +37.3% |
| Q3 2021 | $41,036,000 | – | 455,000 | – | 0.91% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| First Light Asset Management, LLC | 437,512 | $31,772,000 | 2.80% |
| RTW INVESTMENTS, LP | 1,373,284 | $99,728,000 | 2.06% |
| Rock Springs Capital Management LP | 1,028,109 | $74,661,000 | 1.88% |
| Privium Fund Management B.V. | 112,727 | $8,186,000 | 1.81% |
| Avidity Partners Management LP | 869,000 | $63,107,000 | 1.31% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 525,100 | $38,133,000 | 1.16% |
| Boxer Capital, LLC | 200,000 | $14,524,000 | 0.75% |
| SECTOR GAMMA AS | 46,221 | $3,357,000 | 0.73% |
| FEDERATED HERMES, INC. | 3,987,728 | $289,589,000 | 0.65% |
| EMERALD ADVISERS, LLC | 223,952 | $16,263,000 | 0.62% |